Biotech Values

[Whalatane]

MYOK. Biotech Jim ..Also listened to web cast
Yes 2018 will be an active yr . Only thing I didn't like is that their reviewing of final trial protocol with the FDA appears to have been pushed back. From memory of 2017 CC's they always said final meeting with FDA by end of 2017 .
They probably needed the low dose data before the final FDA meeting ....and since they will present that data on March 10th at ACC......I'm assuming final FDA meeting any week now .
That should lift the stock ..when the FDA signs off ...as this will be their pivotal ( P 3 ) trial
JMO
Kiwi